Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents

  • Morales Jiménez, Amanda
  • Cruz, Alejandro
  • Pérez-Sánchez, Álex|||0000-0003-3636-3885
  • D'Avino, Danilo
  • Galassi, Gaia
  • Milano, Erica Ginevra
  • Bernareggi, Irene
  • Arenós-Bach, Carla|||0009-0002-0297-539X
  • Grazioso, Giovanni
  • Alibés, Ramon|||0000-0002-7997-2691
  • Hernando, Jordi|||0000-0002-1126-4138
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo|||0000-0001-6939-3859
  • Busqué, Félix|||0000-0001-7566-4264
  • González Lafont, Àngels|||0000-0003-0729-2483
  • Lluch, José M.|||0000-0002-7536-1869
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib─the most widely used COX-2 selective NSAID─three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Three-photon infrared stimulation of endogenous neuroreceptors in vivo

  • Sortino, Rosalba|||0000-0002-8854-6782
  • Cunquero, Marina|||0000-0001-8093-8186
  • Castro-Olvera, Gustavo|||0000-0001-9843-3581
  • Gelabert, Ricard|||0000-0001-6506-5786
  • Moreno, Miquel|||0000-0002-2784-1307
  • Riefolo, Fabio|||0000-0002-6762-2619
  • Matera, Carlo|||0000-0001-6939-3859
  • Fernàndez-Castillo, Noèlia|||0000-0001-9948-0312
  • Agnetta, Luca
  • Decker, Michael
  • Lluch, José M.|||0000-0002-7536-1869
  • Hernando, Jordi|||0000-0002-1126-4138
  • Loza-Alvarez, Pablo|||0000-0002-3129-1213
  • Gorostiza, Pau|||0000-0002-7268-5577
To interrogate neural circuits and crack their codes, in vivo brain activity imaging must be combined with spatiotemporally precise stimulation in three dimensions using genetic or pharmacological specificity. This challenge requires deep penetration and focusing as provided by infrared light and multiphoton excitation, and has promoted two-photon photopharmacology and optogenetics. However, three-photon brain stimulation in vivo remains to be demonstrated. We report the regulation of neuronal activity in zebrafish larvae by three-photon excitation of a photoswitchable muscarinic agonist at 50 pM, a billion-fold lower concentration than used for uncaging, and with mid-infrared light of 1560 nm, the longest reported photoswitch wavelength. Robust, physiologically relevant photoresponses allow modulating brain activity in wild-type animals with spatiotemporal and pharmacological precision. Computational calculations predict that azobenzene-based ligands have high three-photon absorption cross-section and can be used directly with pulsed infrared light. The expansion of three-photon pharmacology will deeply impact basic neurobiology and neuromodulation phototherapies.